Survival of Patients with Newly Diagnosed Glioblastoma Treated with Radiation and Temozolomide on Research Studies in the United States

PURPOSE: Novel agents are currently combined with radiation and temozolomide (RT+TMZ) in newly diagnosed glioblastoma using overall survival as the primary endpoint. Results of these phase II studies are typically compared to the phase III EORTC survival data that resulted in RT+TMZ becoming standar...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Grossman, Stuart A., Ye, Xiaobu, Piantadosi, Steven, Desideri, Serena, Nabors, Louis B., Rosenfeld, Myrna, Fisher, Joy
Formato: Artigo
Lenguaje:Inglês
Publicado: 2010
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2861898/
https://ncbi.nlm.nih.gov/pubmed/20371685
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-09-3106
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares